Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm Female
Interventions: DRUG: Venetoclax|DRUG: Palbociclib|DRUG: Letrozole
Sponsor: Peter MacCallum Cancer Centre, Australia